Karyopharm Therapeutics I...

NASDAQ: KPTI · Real-Time Price · USD
4.51
0.12 (2.73%)
At close: Jun 16, 2025, 3:59 PM
4.64
2.77%
After-hours: Jun 16, 2025, 07:59 PM EDT

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics reported an annual revenue of $145.24M, reflecting a -0.55% growth. For the quarter ending March 31, 2025, Karyopharm Therapeutics generated $30.02M in revenue.
Revenue (ttm)
$145.24M
Revenue Growth
-0.55%
Price / Sales Ratio
8.51
Revenue / Employee
$520.56K
Employees
279
Market Cap
39.01M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.